Clinical & scientific research · PII
PI insurance for UK clinical research and scientific-professional services
Reviewed by Matthew Bartlett, Director, Apex Insurance Brokers Limited · Published 14 July 2026
Clinical research organisations, scientific consultants, and life-sciences professionals face distinctive PI considerations. Human-participant protection, regulatory approval, protocol design, data integrity, and interaction with medical negligence all shape the market. This page maps the UK PI landscape.
Who this applies to
- Clinical research organisations (CROs) conducting clinical trials.
- Contract research organisations for preclinical, laboratory or specialist studies.
- Scientific consultants in pharma, biotech, medical devices.
- Regulatory-affairs consultants supporting MHRA / EMA / FDA submissions.
- Health-economics and outcomes research consultants.
- Statisticians and biostatisticians supporting clinical trial design.
- Independent scientific advisers to healthcare, food or environmental sectors.
Regulatory framework
- MHRA (Medicines and Healthcare products Regulatory Agency) supervises clinical trials of medicinal products.
- Clinical Trials Regulations 2004 and Good Clinical Practice (GCP) guidelines.
- Human Tissue Act 2004 for tissue-based research.
- Data Protection Act 2018 / UK GDPR for research data.
- NHS Health Research Authority (HRA) approvals for research involving NHS.
- Specific-role regulation for medical professionals conducting research alongside their clinical practice.
Common claim triggers
- Protocol-design errors. Trial protocol fails to demonstrate what was intended; sponsor incurs cost or regulatory challenge.
- GCP breach. Good Clinical Practice deviations identified in audit.
- Human-participant harm allegations. Distinct from medical negligence — researcher-role liability.
- Data-integrity concerns. Research data quality challenged.
- Regulatory submission failures. Consultant's regulatory advice results in approval delay or rejection.
- Publication and misconduct claims. Research-integrity allegations.
Cover types for research organisations
- Standard PI for the professional advisory and consulting work.
- Clinical trial insurance covering participant-injury exposure — distinct from PI but often bundled.
- Medical malpractice cover where clinicians participate in research alongside clinical practice.
- Product-liability cover for firms with proprietary devices or compounds.
- Cyber cover for research data and IT systems.
Cover-sizing
- Small clinical consultancy — £2m-£5m per claim typical.
- CRO conducting Phase III trials — £10m-£25m per claim plus specific clinical-trial insurance.
- Large multinational CRO — layered programmes with £50m+.
- Individual scientific-adviser practice — £1m-£5m depending on client type.
- Health-economics consultants — £2m-£10m depending on client sector.
Getting cover in place
- Distinguish participant-injury cover from professional-advisory PI.
- Confirm the wording covers the specific research activities.
- Consider territorial extensions for cross-border studies.
- Integrate with sponsor's insurance arrangements where sponsor is a pharmaceutical company.
- Regulatory-investigation cover for MHRA / HRA engagement.
- Specialist broker with life-sciences experience essential for complex CRO placements.
Frequently asked
Do UK clinical research organisations need specialist PI cover?
Yes typically. Standard commercial PI rarely covers the specific research activities. Specialist wordings address protocol design, GCP compliance, and research-specific claim types.
What is clinical trial insurance and how is it different from PI?
Clinical trial insurance is specific participant-injury cover for trial subjects — distinct from professional-liability PI. Both typically needed by CROs; often bundled. Sponsor usually holds primary participant-injury cover.
How does PI interact with medical malpractice for researcher-clinicians?
Where a clinician also does research, medical malpractice covers their clinical practice; PI covers their research advisory activity. Some professionals hold both; some hold combined cover addressing both roles.
Do UK CROs face specific regulatory investigation exposure?
Yes. MHRA and HRA can investigate CRO practices. Serious Non-Compliance findings can trigger civil and regulatory consequences. PI regulatory-investigation cover addresses defence.
What if I'm an individual scientific adviser without an institutional employer?
Individual PI cover essential. Cover-sizing reflects the type of client and the potential impact of advisory failures. Corporate pharma or biotech clients typically require £5m+.
Does my university's cover extend to me for external consulting?
Typically no. University cover applies to institutional research; external consulting activity typically requires separate personal cover. Confirm with your institution before undertaking external work.
What about publication misconduct or authorship disputes?
Research-integrity claims can trigger PI in some circumstances. Standard PI wordings vary in coverage — some cover research-misconduct defence; some don't. Confirm at inception.
Do international clinical trials need US-market cover?
For US-connected trials, US-market cover often required by sponsors and regulators. Territorial scope must address the specific jurisdictions. Specialist broker with US-market access typically needed.